Erythromycin salt of the o-carbonyl(1-thiazolidinyl)-benzoic aci

Details Erythromycin salt of the o-carbonyl(1-thiazolidinyl)-benzoic aci Erythromycin salt of the o-carbonyl(1-thiazolidinyl)-benzoic aci

1983-12-15

1986-03-11

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 72, A61K 3171, C07H 1708

Patent

active

045754969

ABSTRACT:
The present invention concerns the new erythromycin salt of the o-carbonyl(1-thiazolidinyl)-benzoic acid having the formula ##STR1## wherein X represents the monovalent cation of erythromycin. The new salt constitutes a novel antibiotic complex for the selective therapy of the respiratory tract.

REFERENCES:
patent: 4264765 (1981-04-01), Bodor et al.
patent: 4396613 (1983-08-01), Kirst

Affiliated with

Also associated with

Rating

Erythromycin salt of the o-carbonyl(1-thiazolidinyl)-benzoic aci does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythromycin salt of the o-carbonyl(1-thiazolidinyl)-benzoic aci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythromycin salt of the o-carbonyl(1-thiazolidinyl)-benzoic aci will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2191583